MINI FUTURE LONG CERTIFICATE - ROCHE GS Share Price

Certificat

ROGHQ

CH0049450809

Market Closed - Swiss Exchange 16:20:01 29/04/2024 BST
21.35 CHF +0.23% Intraday chart for MINI FUTURE LONG CERTIFICATE - ROCHE GS
1 month-3.61%
3 months-7.78%
Date Price Change Volume
29/04/24 21.35 +0.23% 0
26/04/24 21.3 +0.47% 0
25/04/24 21.2 -1.40% 0
24/04/24 21.5 -3.15% 0
23/04/24 22.2 +1.83% 0

Delayed Quote Swiss Exchange

Last update April 29, 2024 at 04:20 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer BNP Paribas BNP Paribas
ROGHQ
ISINCH0049450809
Date issued 10/03/2009
Strike 7.673 CHF
Maturity Unlimited
Parity 10 : 1
Emission price- CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 37.6 CHF
Lowest since issue 3.08 CHF
Spread 0.05 CHF
Spread %0.23%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
220.6 CHF
Average target price
279.4 CHF
Spread / Average Target
+26.65%
Consensus
  1. Stock Market
  2. Certificates
  3. ROGHQ Certificat